(Q58130673)

primary sclerosing cholangitis

inferred from title

1 reference

Christoph Schramm

11

0 references

author name string

Janosch Katt

1

0 references

Dorothee Schwinge

2

0 references

Tanja Schoknecht

3

0 references

Alexander Quaas

4

0 references

Ingo Sobottka

5

0 references

Eike Burandt

6

0 references

Christoph Becker

7

0 references

Markus F. Neurath

8

0 references

Ansgar W. Lohse

9

0 references

Johannes Herkel

EASL Clinical Practice Guidelines: management of cholestatic liver diseases.

10

0 references

language of work or name

English

0 references

publication date

30 July 2013

0 references

published in

Hepatology

0 references

volume

58

0 references

issue

3

0 references

page(s)

1084-1093

0 references

cites work

1 reference

Interactions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitis

21 January 2018

1 reference

Microbial influences in inflammatory bowel diseases

21 January 2018

1 reference

Influence of dominant bile duct stenoses and biliary infections on outcome in primary sclerosing cholangitis

21 January 2018

1 reference

Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis: a randomized placebo-controlled trial

21 January 2018

1 reference

IL-23 and IL-17A, but not IL-12 and IL-22, are required for optimal skin host defense against Candida albicans

21 January 2018

1 reference

Th17 cells mediate clade-specific, serotype-independent mucosal immunity

21 January 2018

1 reference

Th17 and regulatory T cells in mediating and restraining inflammation

21 January 2018

1 reference

Increased expression of interleukin 17 in inflammatory bowel disease

21 January 2018

1 reference

Interleukin-17 and type 17 helper T cells

21 January 2018

1 reference

Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci

21 January 2018

1 reference

Three ulcerative colitis susceptibility loci are associated with primary sclerosing cholangitis and indicate a role for IL2, REL, and CARD9

21 January 2018

1 reference

Excessive CD4+ T cells co-expressing interleukin-17 and interferon-γ in patients with Behçet's disease.

21 January 2018

1 reference

Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β.

21 January 2018

1 reference

Genome-wide association analysis in primary sclerosing cholangitis

21 January 2018

1 reference

Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci

21 January 2018

1 reference

Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense

21 January 2018

1 reference

Th17 cells in human disease.

21 January 2018

1 reference

Electrostatic modifications of the human leukocyte antigen-DR P9 peptide-binding pocket and susceptibility to primary sclerosing cholangitis

21 January 2018

1 reference

IL-23 drives a pathogenic T cell population that induces autoimmune inflammation

21 January 2018

1 reference

Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes

21 January 2018

1 reference

Th1-Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice

21 January 2018

1 reference

T(H)-17 cells in the circle of immunity and autoimmunity

21 January 2018

1 reference

The many faces of Th17 cells

21 January 2018

1 reference

The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells

21 January 2018

1 reference

Role of IL-17 and Th17 cells in liver diseases

21 January 2018

1 reference

Interleukin-17 contributes to the pathogenesis of autoimmune hepatitis through inducing hepatic interleukin-6 expression

21 January 2018

1 reference

Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice

21 January 2018

1 reference

A genome-wide association study identifies IL23R as an inflammatory bowel disease gene

21 January 2018

1 reference

The adaptor protein CARD9 is required for innate immune responses to intracellular pathogens

21 January 2018

1 reference

Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity

21 January 2018

1 reference

Selective C-Rel activation via Malt1 controls anti-fungal T(H)-17 immunity by dectin-1 and dectin-2.

21 January 2018

1 reference

Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17

21 January 2018

1 reference

Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis

21 January 2018

1 reference

Biliary candida infections in primary sclerosing cholangitis

21 January 2018

1 reference

7 January 2021

Bile duct bacterial isolates in primary sclerosing cholangitis: a study of explanted livers.

1 reference

7 January 2021

Fluorescent In situ hybridization allows rapid identification of microorganisms in blood cultures

1 reference

7 January 2021

Update on primary sclerosing cholangitis

1 reference

7 January 2021

Periductal interleukin-17 production in association with biliary innate immunity contributes to the pathogenesis of cholangiopathy in primary biliary cirrhosis

1 reference

7 January 2021

Aberrant responses to TLR agonists in pediatric IBD patients; the possible association with increased production of Th1/Th17 cytokines in response to candida, a luminal antigen

1 reference

7 January 2021